Corbus Pharmaceuticals Holdings (CRBP) Non Operating Interest Expenses (2013 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) posted Non Operating Interest Expenses of $381000.0 for Q3 2024, down 41.56% on a QoQ basis from $652000.0 in Q2 2024, and down 61.12% year-over-year from $980000.0 in Q4 2023.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Non Operating Interest Expenses (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings has reported Non Operating Interest Expenses for 6 years, with the latest figure at $381000.0 in Q3 2024.
- On a quarterly basis, Non Operating Interest Expenses fell 61.12% year-over-year to $381000.0 in Q3 2024; TTM through Jun 2025 was $381000.0, a 88.8% decrease from a year earlier, with the FY2024 full-year figure at $1.9 million, down 51.48% from the prior year.
- Non Operating Interest Expenses was $381000.0 for Q3 2024 at Corbus Pharmaceuticals Holdings, down from $652000.0 in the prior quarter.
- The five-year high for Non Operating Interest Expenses was $1.0 million in Q2 2023, with the low at $381000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Corbus Pharmaceuticals Holdings | 101.29 Mn | -61.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 381,000.00 |
| Jun 30, 2024 | 652,000.00 |
| Mar 31, 2024 | 839,000.00 |
| Dec 31, 2023 | 930,000.00 |
| Sep 30, 2023 | 980,000.00 |
| Jun 30, 2023 | 1.01 Mn |
| Mar 31, 2016 | 6,430.00 |
| Dec 31, 2015 | 1,068.00 |
| Jun 30, 2015 | 393.00 |
| Mar 31, 2015 | 979.00 |
| Dec 31, 2014 | 976.00 |
| Sep 30, 2014 | 650.00 |
| Jun 30, 2014 | 11,232.00 |
| Mar 31, 2014 | 11,163.00 |
| Dec 31, 2013 | 13,822.00 |
| Sep 30, 2013 | 9,367.00 |